The YTD outperformance (+4.0% vs -3.8% for the S&P) stands out because it demonstrates that UPBD can generate positive returns when the broader market is negative, positioning the stock as a possible hedge in bearish cycles.
The three‑year and five‑year negative annual returns (-12.4% and -18.5%) signal that despite relative outperformance, the stock is still in a prolonged decline phase; continued earnings pressure or slower adoption of its cloud‑native platform could deepen losses, eroding investor confidence.
The near‑full institutional ownership also means the stock is vulnerable to large, coordinated sell‑offs; if even a small fraction of the 1.21% free float were liquidated rapidly, it could exacerbate price volatility given the already high beta and historical drawdown levels.
The 8.67% YoY revenue surge—more than double the three‑year CAGR—signals a potentially durable growth inflection, likely driven by higher-margin service mix or new contract wins that could sustain earnings acceleration.
Operating margin of 4.8% is vulnerable; a 1% increase in SG&A would cut operating profit by roughly $236 M, eroding profitability and pressuring cash flow if cost discipline slips.
The conversion of a -26.4% loss margin to a positive 1.6% margin is the standout profitability driver, as it alone accounts for roughly a 28-percentage-point swing in ROE and signals that core operations are finally scaling profitably.
| Year | ROE% | Margin% | Turnover | Leverage | ROIC% | ROCE% | ROA% |
|---|---|---|---|---|---|---|---|
| 2025 | 10.5 | 1.6 | 1.43 | 4.71 | 8.9 | 8.7 | 2.2 |
| 2024 | 19.6 | 2.9 | 1.63 | 4.21 | 14.2 | 13.7 | 4.7 |
| 2023 | -0.9 | -0.1 | 1.47 | 4.86 | 8.0 | 7.7 | -0.2 |
| 2022 | 2.4 | 0.3 | 1.54 | 5.26 | 7.1 | 6.8 | 0.4 |
| 2021 | 26.3 | 2.9 | 1.53 | 5.83 | 11.6 | 11.0 | 4.5 |
| 2020 | 35.1 | 7.4 | 1.61 | 2.96 | 18.7 | 18.2 | 11.9 |
| 2019 | 37.8 | 6.5 | 1.69 | 3.45 | 21.7 | 21.4 | 11.0 |
| 2018 | 3.0 | 0.3 | 1.90 | 4.88 | 5.4 | 5.3 | 0.6 |
| 2017 | 2.4 | 0.2 | 1.90 | 5.21 | -5.5 | -5.5 | 0.5 |
| 2016 | -42.8 | -3.8 | 1.85 | 6.05 | -5.2 | -5.2 | -7.1 |
| 2015 | -184.2 | -26.4 | 1.65 | 4.22 | -60.0 | -60.0 | -43.6 |
The 154‑day cash conversion cycle represents a capital efficiency concern; it ties up roughly one third of annual sales in working capital, which could force the company to rely on external financing if operating cash flow does not improve.
| Year | Total Asset Days | Inventory Days | Receivables Days | Fixed Asset Days | Payables Days | Cash Conversion Cycle |
|---|---|---|---|---|---|---|
| 2025 | 255 | 157 | 16 | 45 | 18 | 154 |
| 2024 | 224 | 0 | 13 | 44 | 19 | -6 |
| 2023 | 249 | 230 | 10 | 51 | 33 | 207 |
| 2022 | 238 | 191 | 10 | 51 | 26 | 174 |
| 2021 | 238 | 1 | 10 | 152 | 21 | -10 |
| 2020 | 227 | 2 | 12 | 173 | 59 | -46 |
| 2019 | 216 | 2 | 12 | 175 | 60 | -47 |
| 2018 | 192 | 1 | 10 | 142 | 43 | -32 |
| 2017 | 192 | 322 | 9 | 156 | 34 | 298 |
| 2016 | 197 | 1 | 9 | 162 | 38 | -29 |
| 2015 | 221 | 1 | 8 | 163 | 30 | -21 |
| Year | Total Assets | Total Liabilities | Total Equity | Total Debt | Net Debt | Cash | Current Assets | Current Liabilities |
|---|---|---|---|---|---|---|---|---|
| 2025 | $3276M | $2580M | $696M | $1857M | $1736M | $121M | $1799M | $715M |
| 2024 | $2650M | $2021M | $629M | $1583M | $1522M | $61M | $1515M | $521M |
| 2023 | $2721M | $2161M | $560M | $1600M | $1506M | $94M | $1495M | $607M |
| 2022 | $2764M | $2238M | $525M | $1674M | $1530M | $144M | $1434M | $589M |
| 2021 | $2993M | $2480M | $513M | $1868M | $1759M | $108M | $241M | $441M |
| 2020 | $1751M | $1159M | $592M | $476M | $316M | $159M | $305M | $449M |
| 2019 | $1583M | $1124M | $459M | $516M | $445M | $70M | $206M | $396M |
| 2018 | $1397M | $1110M | $287M | $540M | $385M | $155M | $280M | $330M |
| 2017 | $1421M | $1148M | $272M | $673M | $600M | $73M | $211M | $284M |
| 2016 | $1603M | $1338M | $265M | $724M | $629M | $95M | $224M | $325M |
| 2015 | $1987M | $1517M | $470M | $968M | $908M | $60M | $306M | $308M |
| Year | Operating CF | Investing CF | Financing CF | CapEx | Free Cash Flow | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| 2025 | $306M | $-404M | $156M | $-67M | $239M | $-88M | |
| 2024 | $105M | $-42M | $-94M | $-56M | $48M | $-82M | |
| 2023 | $200M | $-51M | $-202M | $-53M | $147M | $-50M | $-83M |
| 2022 | $468M | $-62M | $-371M | $-61M | $407M | $-75M | $-79M |
| 2021 | $392M | $-1336M | $893M | $-62M | $330M | $-390M | $-72M |
| 2020 | $237M | $-21M | $-127M | $-35M | $202M | $-27M | $-63M |
| 2019 | $215M | $21M | $-322M | $-21M | $194M | $-1M | $-14M |
| 2018 | $228M | $-5M | $-140M | $-28M | $200M | $-0M | |
| 2017 | $111M | $-63M | $-71M | $-65M | $45M | $-13M | |
| 2016 | $354M | $-59M | $-259M | $-61M | $293M | $-0M | $-26M |
| 2015 | $230M | $-90M | $-124M | $-81M | $150M | $-1M | $-51M |
This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.
The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.
Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.
Created 2026-06-07 · finexus.net